Evaluation of deep brain stimulation in idiopathic Parkinson's disease: progress report

L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES)
Record ID 32003000042
French
Authors' objectives:

To assess the efficacy, safety and surgical technique of deep brain stimulation (DBS) to treat idiopathic Parkinson's disease.

Authors' results and conclusions: (i)Definition: High frequency deep brain stimulation (DBS) is a form of functional stereotactic surgery which offers an alternative to lesional surgery. It involves implanting electrodes to stimulate one of the three target nuclei in the brain: the ventral intermediate nucleus of the thalamus (VIM), the globus pallidus internus (Gpi) and the subthalamic nucleus (STN). (ii) Studies selected: Three summary reviews and 10 clinical trials of a low level of evidence (3 randomised controlled trials (lesional surgery vs DBS); 2 non-randomised trials comparing stimulation of the Gpi and STN; the remainder were case series). (iii) Indications: DBS is restricted to patients suffering from severe Parkinson's disease who no longer respond to medical treatment, but who nevertheless retain good sensitivity to levadopa therapy and sufficiently good general and mental health to allow them to undergo surgery. (iv) Efficacy and safety: DBS has been shown to be feasible, but it is not yet possible to draw conclusions concerning its theoretical advantages (efficacy compared with lesional surgery or with optimum medical therapy, the possibility of bilateral stimulation without increasing the complications, and its reversibility) or its benefit-risk ratio. (v) Implementation: DBS consists of a complex sequence of diagnostic and therapeutic actions which are specific to each of the French centres. Surgery has to be carried out in a hospital with appropriate high-technology equipment and an experienced multidisciplinary team with the right skills.
Authors' recommendations: (i) A longitudinal prospective cohort study needs to be carried out with the participation of all the French centres to monitor the results from current practice. (ii) Multicentre, randomised controlled trials to be carried out: first of all, a randomised clinical trial comparing DBS with the best medical management, followed by trials to determine the best target nucleus and the best surgical technique. (iii) Awareness needs to be raised among the different teams to encourage them to improve their reporting of medical device vigilance incidents.
Authors' methods: Systematic review
Details
Project Status: Completed
URL for project: http://www.has-sante.fr/
Year Published: 2003
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: France
MeSH Terms
  • Electric Stimulation Therapy
  • Parkinson Disease
Contact
Organisation Name: L'Agence Nationale d'Accreditation d'Evaluation en Santé
Contact Address: 2 avenue du Stade de France, 93218 Saint-Denis La Plaine Cedex, France. Tel: +33 01 55 93 71 88; Fax: +33 01 55 93 74 35;
Contact Name: sh.leerobin@has-sante.fr
Contact Email: sh.leerobin@has-sante.fr
Copyright: L'Agence Nationale d'Accreditation d'Evaluation en Sante (ANAES)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.